H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Census population 681,054. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Oklahoma City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Oklahoma City storefront.
Alternatives to Cortisone Injections in Oklahoma City, OK for clinics & physicians. Looking for cortisone… Compliance support & pricing — contact Hawk Medical.
Oklahoma City is a city of 500k–1M (681,054 Census). CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Adult arthritis here is 25.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Alternatives to Cortisone Injections notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.6% of adults in Oklahoma City have diagnosed diabetes — 0.6 points above the U.S. 12% figure. Adult obesity in Oklahoma City is 38.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 25.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, TX. Oklahoma State Department of Health is the public-health home. We will not mash those grains into a fake “demand score.”
If you already buy cortisone injection alternatives elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 12.6% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 12.6% of adults — 0.6 points above the U.S. 12% figure. Obesity is 38.3%; arthritis is 25.8%. That is place-level BRFSS modeling, not a clinic census and not a Oklahoma City trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Oklahoma City.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including Oklahoma. There is no Oklahoma City storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
Ask for the IFU, the lot-traceability packet, and the Novitas Solutions article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Oklahoma City fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Oklahoma City, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Oklahoma City is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Oklahoma City — 0.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Oklahoma City. Useful for joint-program math; still needs a diagnosis and privileging.
No Oklahoma City storefront. Joe Bradley is an active practice owner. cortisone injection alternatives stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.